Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Merck & Co. and Celera extend osteoporosis collaboration for sixth year

Dec. 18, 2001

Efficacy of ARGENT-Epo regulated gene expression therapy demonstrated in mouse model

Dec. 14, 2001

Approvable letter expands use and formulations of Vivelle-Dot

Dec. 14, 2001

CPMP recommends approval of Dynepo for anemia of renal failure

Dec. 13, 2001

Somatostatin sst2 receptor antagonists synthesized at Pfizer elevate GH secretion

Dec. 13, 2001

First phase III trial of AC-2993 for type 2 diabetes under way

Dec. 13, 2001

Trio of pharmaceutical companies jointly design potential agents for bone disorders

Dec. 12, 2001

Novel compounds for lipid disorders emerge from R&D at Novartis

Dec. 12, 2001

GSK and Roche to codevelop and copromote ibandronate

Dec. 12, 2001

GSK-3 inhibitors and use in diabetes and other disorders

Dec. 11, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...